Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03653468
Other study ID # 28082018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2018
Est. completion date August 25, 2018

Study information

Verified date August 2018
Source Universidad Santo Tomas
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities. Thus, is yet unknown the effects and influence of the concurrent training (CT) eliciting responders (R) and non-responders (NR) cases (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes).


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date August 25, 2018
Est. primary completion date May 28, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 59 Years
Eligibility Inclusion Criteria:

- Written informed consent

- Interested in improving health and fitness

Exclusion Criteria:

- Cardiovascular contraindications to exercise

- History of stroke, asthma or chronic obstructive pulmonary disease, muscle-skeletal disorders

- Smoking

- A compliance rate to the exercise program = 70% was required for the participants in the intervention group to be included in the statistical analyses.

Study Design


Intervention

Behavioral:
Concurrent training (CT)
The core part of each session included resistance training (RT) followed by aerobic training exercises (for 50 and 30 minutes, respectively) and was preceded and followed by a 5-minute warm-up and cool-down with callisthenic movements.

Locations

Country Name City State
Chile Cristian Alvarez Los Lagos Osorno

Sponsors (5)

Lead Sponsor Collaborator
Universidad Santo Tomas Healthcare Center Tomas Rojas, Universidad de Los Lagos, Universidad del Rosario, Universidad Pública de Navarra

Country where clinical trial is conducted

Chile, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fasting glucose Change from Baseline in fasting glucose Baseline and 20-weeks immediately after the interventions ends
Primary Total cholesterol Change from baseline in Total cholesterol Baseline and 20-weeks immediately after the interventions ends
Primary Blood pressure Change from baseline in Blood pressure Baseline and 20-weeks immediately after the interventions ends
Secondary Body mass Change from Baseline in body mass Baseline and 20-weeks immediately after the interventions ends
Secondary Waist circumference Change from Baseline in waist circumference Baseline and 20-weeks immediately after the interventions ends
Secondary Fat mass Change from Baseline in fat mass Baseline and 20-weeks immediately after the interventions ends
Secondary Lean mass Change from Baseline in lean mass Baseline and 20-weeks immediately after the interventions ends
Secondary Heart rate at rest Change from Baseline in heart rate at rest Baseline and 20-weeks immediately after the interventions ends
Secondary Six minutes walking test Change from Baseline in six minutes walking test Baseline and 20-weeks immediately after the interventions ends
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2